Skip to content

Clinical trials

Phase 3 Respiratory Tract Infections trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Respiratory Tract Infections Phase: Phase 3 Clear all

93 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20041
20056
20062
20071
20086
20094
20103
20112
20126
20137
20142
20153
20162
20174
20182
20194
20208
20214
20224
20231
20248
20254
20264

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed58
Recruiting13
Terminated10
Unknown status7
Withdrawn4
Not yet recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Pfizer7
GlaxoSmithKline4
Novartis4
Insmed Incorporated3
Medicago3
Assistance Publique - Hôpitaux de Paris2
Bayer2
BioNTech SE2
Daewon Pharmaceutical Co., Ltd.2
Emory University2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Respiratory Tract Infections93
Infections16
Respiratory Tract Diseases15
Influenza, Human14
Pneumonia14
COVID-1913
Virus Diseases13
Lung Diseases11
RNA Virus Infections9
Coronavirus Infections8

Trials

Showing 51 to 75 of 93. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.